Daniel P. Raymond

Cancer Institute (WIA), Cleveland Clinic

Papers

4

Total Citations

77

H-Index

4

About

Daniel P. Raymond is a thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques and improving perioperative outcomes for patients with thoracic diseases. His major contributions lie in evaluating the comparative effectiveness of robotic and open surgical approaches, particularly for lung cancer and esophageal disorders. In a pivotal 2020 study (42 citations), he demonstrated that robotic lobectomy achieves nodal upstaging comparable to open lobectomy for clinical stage I non-small cell lung cancer, challenging assumptions about the adequacy of minimally invasive staging. Raymond has also pioneered research in regional anesthesia for thoracic surgery, notably through a 2024 randomized trial (8 citations) testing combined pectoralis and serratus anterior plane blocks with liposomal bupivacaine to extend analgesia and reduce opioid reliance. His work on robotic versus laparoscopic Heller myotomy (22 citations) further underscores his commitment to optimizing surgical precision. Additionally, his 2013 case report on esophagopulmonary fistula after transoral incisionless fundoplication (5 citations) highlights his attention to rare complications. With over 75 total citations, Raymond’s research directly informs clinical practice, balancing innovation with rigorous evidence to enhance recovery and safety in thoracic surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
77
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer
42 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Cancer Institute (WIA), Cleveland Clinic

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago